Table 3.
DE transcript group | Cell type | EAE TH cell list size | Overlapping genes | p-value | Adjusted p-value |
---|---|---|---|---|---|
CDT | TH1 | 150 | 10 | 6.5 × 10−4 | 5.2 × 10−3 |
TH17 | 30 | 3 | 2.1 × 10−2 | 1.1 × 10−1 | |
OSE4sp | TH1 | 215 | 10 | 9.7 × 10−3 | 5.8 × 10−2 |
TH17 | 41 | 3 | 4.7 × 10−2 | 1.6 × 10−1 | |
MOG4sp | TH1 | 37 | 1 | 5.1 × 10−1 | 5.1 × 10−1 |
TH17 | 7 | 1 | 1.3 × 10−1 | 2.6 × 10−1 | |
OSE1ex | TH1 | 60 | 6 | 1.1 × 10−3 | 7.7 × 10−3 |
TH17 | 16 | 2 | 3.9 × 10−2 | 1.6 × 10−1 |
The p-values were computed using 100,000 permutations. Enrichments significant after Holm-Bonferroni correction for multiple testing (eight tests) are highlighted in bold font (adjusted p-value < 0.05). DE, differentially expressed; WT, wildtype; CDT, common disease transcripts (differentially expressed for both contrasts OSE4-OSE0 and MOG4-CFA but not in the two control contrasts OSE0-WT or CFA-WT); OSE4sp, OSE4-specific transcripts (differentially expressed for the contrast OSE4-OSE0 but not in MOG4-CFA, OSE0-WT, or CFA-WT); MOG4sp, MOG4 -specific transcripts (differentially expressed for the contrast MOG4-CFA but not in OSE4-OSE0, OSE0-WT, or CFA-WT); OSE1ex, OSE1-specific transcripts (differentially expressed in OSE1-OSE0 but not in OSE0-WT or CFA-WT).